Riverwood Capital

Sathlokhar Synergys IPO GMP, Review, Price, Allotment

Sathlokhar Synergys IPO GMP, Review, Price, Allotment

Sathlokhar Synergys IPO description – Sathlokhar Synergys E&C Global is an EPC (Engineering, Procurement, and Construction) and turnkey contracting powerhouse. They specialize in crafting solutions for a diverse array of projects ranging from industrial structures to warehousing hubs, commercial edifices, institutional complexes, and pharmaceutical facilities. Their expertise also spans solar initiatives, hospitals, luxurious hotels, serene resorts, […]

Sathlokhar Synergys IPO GMP, Review, Price, Allotment Read More »

Nirman Agri Rights Issue Date, Price, Market Lot, Subscription 2024

Nirman Agri Rights Issue Date, Price, Market Lot, Subscription 2024

Nirman Agri Rights Issue is scheduled on 5 – 23 Aug 2024 Nirman Agri Genetics is a leading agri-input company in India, engaged in the production, processing, and marketing of high-quality hybrid seeds, pesticides, and bio-organic products for various crops such as corn, sunflower, cotton, paddy, and grain sorghum. Recently, the company has expanded into

Nirman Agri Rights Issue Date, Price, Market Lot, Subscription 2024 Read More »

Trom Industries IPO GMP, Review, Price, Allotment

Trom Industries IPO GMP, Review, Price, Allotment

Trom Industries IPO description – Trom Industries is a Solar EPC (Engineering, Procurement, and Construction) company specializing in a variety of solar solutions, including residential rooftop systems, industrial solar power plants, ground-mounted solar installations, and solar street lights. Trom is dedicated to the comprehensive development of diverse solar projects. The company’s product portfolio includes Solar Products:

Trom Industries IPO GMP, Review, Price, Allotment Read More »

Esprit Stones IPO GMP, Review, Price, Allotment

Esprit Stones IPO GMP, Review, Price, Allotment

Esprit Stones IPO description – Esprit Stones specializes in crafting Engineered Stones, focusing on two main products: engineered quartz surfaces and engineered marble surfaces. These Engineered Stones are composite materials that bond crushed stone with a strong adhesive. As of March 2024, Manufacturing Facility I boasts three pressing lines and two polishing lines, producing approximately 72

Esprit Stones IPO GMP, Review, Price, Allotment Read More »

Eight IPOs To Keep Investors Busy

Eight IPOs To Keep Investors Busy

In India’s primary market, next week is likely to be interesting with as many as eight companies going public with initial public offerings (IPOs). With industries spanning from telecommunications and fintech to infrastructure and education, investors will have plenty of options to choose from while also navigating the uncertainty as a result of union budget

Eight IPOs To Keep Investors Busy Read More »

Aprameya Engineering IPO GMP, Review, Price, Allotment

Aprameya Engineering IPO GMP, Review, Price, Allotment

Aprameya Engineering IPO description – Aprameya Engineering specializes in installing, setting up, and maintaining Intensive Care Units (ICU), Neonatal Intensive Care Units (NICU), Pediatric Intensive Care Units (PICU), Operation Theatres, and prefabricated structure wards in hospitals and medical care centers on a turnkey basis. It also supplies high-value healthcare and diagnostic equipment to private hospitals, government

Aprameya Engineering IPO GMP, Review, Price, Allotment Read More »

A Compelling Opportunity For Investors – IPO Central

A Compelling Opportunity For Investors – IPO Central

As Sanstar Limited prepares for its initial public offering (IPO), potential investors have a unique opportunity to delve into the financial and operational strengths of one of India’s prominent manufacturers of plant-based specialty products and ingredient solutions. Through this Sanstar IPO Analysis, IPO Central tries to find out more about the company’s business, financial performance,

A Compelling Opportunity For Investors – IPO Central Read More »

Aurobindo Pharma Buyback Record Date 2024, Acceptance Ratio, Profit Guidance

Aurobindo Pharma Buyback Record Date 2024, Acceptance Ratio, Profit Guidance

Aurobindo Pharma Buyback Record Date is finalized.  Aurobindo Pharma is a leading Indian pharmaceutical company founded in 1986. Aurobindo manufactures and markets generic pharmaceuticals and active pharmaceutical ingredients (APIs) across major therapeutic areas such as antibiotics, antiretrovirals, central nervous system, cardiovascular, anti-diabetics, and more. The company has a large diversified product portfolio with over 870

Aurobindo Pharma Buyback Record Date 2024, Acceptance Ratio, Profit Guidance Read More »

Scroll to Top